Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial. [electronic resource]
Producer: 20191113Description: 2247-2253 p. digitalISSN:- 1569-8041
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- B7-H1 Antigen -- analysis
- Dose-Response Relationship, Drug
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Neoplasm Staging
- Papillomaviridae -- isolation & purification
- Progression-Free Survival
- Response Evaluation Criteria in Solid Tumors
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.